NO781505L - Tilberedning for behandling av dyr. - Google Patents
Tilberedning for behandling av dyr.Info
- Publication number
- NO781505L NO781505L NO781505A NO781505A NO781505L NO 781505 L NO781505 L NO 781505L NO 781505 A NO781505 A NO 781505A NO 781505 A NO781505 A NO 781505A NO 781505 L NO781505 L NO 781505L
- Authority
- NO
- Norway
- Prior art keywords
- magnesium
- preparation
- animals
- stated
- chloride
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 31
- 238000002360 preparation method Methods 0.000 title claims description 19
- 239000011777 magnesium Substances 0.000 claims description 23
- 229910052749 magnesium Inorganic materials 0.000 claims description 17
- 229940091250 magnesium supplement Drugs 0.000 claims description 17
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- QYOBXHXZJRPWDE-JIZZDEOASA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate;chloride Chemical compound [Mg+2].Cl.[O-]C(=O)[C@@H](N)CC([O-])=O QYOBXHXZJRPWDE-JIZZDEOASA-L 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 5
- -1 magnesium dicarboxylic acid salt Chemical class 0.000 claims description 4
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 claims description 4
- WQAQVZMASSANIM-QTNFYWBSSA-L magnesium;(2s)-2-amino-5-hydroxy-5-oxopentanoate;chloride Chemical compound [Mg+2].Cl.[O-]C(=O)[C@@H](N)CCC([O-])=O WQAQVZMASSANIM-QTNFYWBSSA-L 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- MYUGVHJLXONYNC-UHFFFAOYSA-L magnesium diglutamate Chemical compound [Mg+2].OC(=O)C(N)CCC([O-])=O.OC(=O)C(N)CCC([O-])=O MYUGVHJLXONYNC-UHFFFAOYSA-L 0.000 claims description 2
- 235000013918 magnesium diglutamate Nutrition 0.000 claims description 2
- 239000004240 magnesium diglutamate Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- 241000282887 Suidae Species 0.000 description 16
- 230000032258 transport Effects 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 8
- 230000001624 sedative effect Effects 0.000 description 8
- 241000283086 Equidae Species 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000932 sedative agent Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960001983 magnesium aspartate Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002681 magnesium compounds Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2720288A DE2720288C2 (de) | 1977-05-05 | 1977-05-05 | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781505L true NO781505L (no) | 1978-11-07 |
Family
ID=6008177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO781505A NO781505L (no) | 1977-05-05 | 1978-04-28 | Tilberedning for behandling av dyr. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4192865A (de) |
| JP (1) | JPS5417128A (de) |
| AT (1) | AT362222B (de) |
| AU (1) | AU516768B2 (de) |
| BE (1) | BE866573A (de) |
| CA (1) | CA1112574A (de) |
| CH (1) | CH634546A5 (de) |
| DE (1) | DE2720288C2 (de) |
| FR (1) | FR2389378B1 (de) |
| GB (1) | GB1575994A (de) |
| NL (1) | NL7804626A (de) |
| NO (1) | NO781505L (de) |
| NZ (1) | NZ187136A (de) |
| SE (1) | SE437918B (de) |
| ZA (1) | ZA782482B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5505968A (en) * | 1993-07-02 | 1996-04-09 | Her Majesty The Queen In Right Of Canada, As Represented By The Department Of Agriculture | Antemortem nutrient supplement for livestock |
| EP1222861A1 (de) * | 2000-12-22 | 2002-07-17 | Nabuurs Groep B.V. | Antemortem Zusatz für Tiere |
| RS53744B1 (en) * | 2008-09-18 | 2015-06-30 | Elanco Animal Health Ireland Limited | USE OF AZAPERONS TO IMPROVE GROWTH |
| US9913858B2 (en) | 2013-11-20 | 2018-03-13 | Meat & Livestock Australia Limited | Prevention and treatment of toxicosis |
| BR112016011554B1 (pt) | 2013-11-20 | 2021-02-02 | Charles Sturt University | uso de brometo para minimizar ou prevenir a indução de inanição relacionada ao estresse ou inanição relacionada à ansiedade em um animal durante, ou em conclusão de, uma prática de comercialização ou gestão |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1135923B (de) * | 1959-11-05 | 1962-09-06 | M Y F Ferrer & Cia Ltda Lab | Verfahren zur Herstellung von Magnesiumglutamat-Hydrobromid |
| US3836668A (en) * | 1960-12-27 | 1974-09-17 | Ferrer Labor | Therapeutic composition and method of treating patients therewith |
| DE1809119C3 (de) * | 1968-11-15 | 1973-12-20 | Verla-Pharm Arzneimittelfabrik, Apotheker H.J.V.Ehrlich, 8132 Tutzing | Infarktprophylaktikum |
| DE1809121C3 (de) * | 1968-11-15 | 1978-04-27 | Verla-Pharm. Arzneimittelfabrik, Apotheker H.J.V. Ehrlich, 8132 Tutzing | Magnesiummonoaspartat-Hydrobromid und dieses enthaltende Arzneimittel |
| DE2228101C3 (de) * | 1972-06-09 | 1979-07-05 | Verla-Pharm. Arzneimittelfabrik, Apotheker H.J. V. Ehrlich, Gmbh & Co Kg, 8132 Tutzing | Verfahren zur Gewinnung von Komplexverbindungen aus Aminodicarbonsäureionen, Magnesiumionen und Halogenidionen |
| DE2507354A1 (de) * | 1975-02-20 | 1976-09-09 | Verla Pharm | Pharmazeutische zubereitung |
-
1977
- 1977-05-05 DE DE2720288A patent/DE2720288C2/de not_active Expired
- 1977-09-13 CH CH1118777A patent/CH634546A5/de not_active IP Right Cessation
-
1978
- 1978-03-01 ZA ZA00782482A patent/ZA782482B/xx unknown
- 1978-04-21 SE SE7804556A patent/SE437918B/sv not_active IP Right Cessation
- 1978-04-27 US US05/900,568 patent/US4192865A/en not_active Expired - Lifetime
- 1978-04-27 CA CA302,140A patent/CA1112574A/en not_active Expired
- 1978-04-28 NO NO781505A patent/NO781505L/no unknown
- 1978-04-28 NL NL7804626A patent/NL7804626A/xx active Search and Examination
- 1978-04-28 BE BE187281A patent/BE866573A/xx not_active IP Right Cessation
- 1978-05-01 NZ NZ187136A patent/NZ187136A/xx unknown
- 1978-05-02 JP JP5325778A patent/JPS5417128A/ja active Pending
- 1978-05-03 AT AT321878A patent/AT362222B/de not_active IP Right Cessation
- 1978-05-03 AU AU35729/78A patent/AU516768B2/en not_active Expired
- 1978-05-04 GB GB17694/78A patent/GB1575994A/en not_active Expired
- 1978-05-05 FR FR7813309A patent/FR2389378B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA782482B (en) | 1979-04-25 |
| AU516768B2 (en) | 1981-06-18 |
| GB1575994A (en) | 1980-10-01 |
| FR2389378B1 (de) | 1981-11-20 |
| DE2720288C2 (de) | 1984-02-16 |
| CA1112574A (en) | 1981-11-17 |
| JPS5417128A (en) | 1979-02-08 |
| DE2720288A1 (de) | 1978-11-16 |
| SE7804556L (sv) | 1978-11-06 |
| US4192865A (en) | 1980-03-11 |
| BE866573A (fr) | 1978-08-14 |
| CH634546A5 (de) | 1983-02-15 |
| NZ187136A (en) | 1980-12-19 |
| ATA321878A (de) | 1980-09-15 |
| SE437918B (sv) | 1985-03-25 |
| AU3572978A (en) | 1979-11-08 |
| FR2389378A1 (de) | 1978-12-01 |
| NL7804626A (nl) | 1978-11-07 |
| AT362222B (de) | 1981-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Coyle et al. | Anesthetics in aquaculture | |
| DE69429920T2 (de) | Antemortem futterzusatz für lebendes vieh | |
| Brown | Anesthesia in fish | |
| EP1758463A1 (de) | Guanidinoessigsäure als futtermittelzusatz | |
| JP2723846B2 (ja) | 飼料及び飼料添加物 | |
| NO781505L (no) | Tilberedning for behandling av dyr. | |
| Galvez et al. | Masculinization of channel catfish Ictalurus punctatus by oral administration of trenbolone acetate | |
| DE1767274C2 (de) | Veterinärmedizinisches Mittel zur Verhütung oder Behandlung von Viruserkrankungen | |
| JPH11506308A (ja) | 動物の排泄物からのにおいを減少させるための組成物 | |
| EP0093123A1 (de) | Verfahren zur herstellung einer zusammensetzung zur erhöhung der ausnutzung (verdaulichkeit) von futter bei tieren. | |
| DE3404315C1 (de) | Verwendung von Inosin-haltigen Wirkstoffen zur Wachstumsfoerderung bei der Mast von Nutztieren | |
| Ozturk et al. | Effects of humic acids on broiler performance and digestive tract traits | |
| CN113163802A (zh) | 饲料添加剂组合物与包括该饲料添加剂组合物的饲料组合物 | |
| US2977230A (en) | Composition and process for controlling the growth rate of live-stock and poultry | |
| Fiems et al. | Effect of duration of a β‐agonist treatment on growth, feed intake and carcass characteristics in finishing bulls | |
| AU598898B2 (en) | Methods for suppressing the endocrine system | |
| DE2338059A1 (de) | Zusammensetzung fuer veterinaergebrauch zur bekaempfung von durchfall | |
| Castaldo et al. | Growth and carcass composition of female turkeys implanted with anabolic agents and fed high-protein and low-protein diets | |
| AU773425B2 (en) | Methods for sedating and anaesthetising aquatic organisms | |
| AU2004240168B2 (en) | Composition and method | |
| US2504401A (en) | Animal feed | |
| JPH078197B2 (ja) | 食肉用天然保存料及びその製法 | |
| AU2004100062A4 (en) | Composition and method | |
| WO1995017176A1 (en) | Methods for sedating and anaesthetising aquatic organisms | |
| Scott | Prevention of enlarged hock disease in turkeys and ducks |